[HTML][HTML] Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea, HC Rischke, A Bunea… - Radiation …, 2018 - Springer
Background To assess the effect of radiochemotherapy (RCT) on proposed tumour hypoxia
marker transverse relaxation time (T2*) and to analyse the relation between T2* and 18 F …

[PDF][PDF] Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea, HC Rischke, A Bunea… - 2018 - scholar.archive.org
Background: To assess the effect of radiochemotherapy (RCT) on proposed tumour hypoxia
marker transverse relaxation time (T2*) and to analyse the relation between T2* and 18F …

[PDF][PDF] Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea, HC Rischke, A Bunea… - 2018 - academia.edu
Background: To assess the effect of radiochemotherapy (RCT) on proposed tumour hypoxia
marker transverse relaxation time (T2*) and to analyse the relation between T2* and 18F …

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.

N Wiedenmann, H Bunea, HC Rischke… - Radiation …, 2018 - search.ebscohost.com
Abstract < bold> Background: </bold> To assess the effect of radiochemotherapy
(RCT) on proposed tumour hypoxia marker transverse relaxation time (T2*) and to analyse …

[引用][C] Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea, HC Rischke, A Bunea… - Radiation …, 2018 - Springer
Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO
PET derived hypoxia and FDG PET Page 1 CORRECTION Open Access Correction to: Effect …

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea, HC Rischke, A Bunea… - Radiation …, 2018 - go.gale.com
Background To assess the effect of radiochemotherapy (RCT) on proposed tumour hypoxia
marker transverse relaxation time (T2*) and to analyse the relation between T2* and. sup …

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea, HC Rischke… - Radiation …, 2018 - search.proquest.com
Background To assess the effect of radiochemotherapy (RCT) on proposed tumour hypoxia
marker transverse relaxation time (T2*) and to analyse the relation between T2* and 18 F …

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea, HC Rischke… - Radiation Oncology …, 2018 - inis.iaea.org
Available from http://dx. doi. org/10.1186/s13014-018-1103-1; Available from http://www.
ncbi. nlm. nih. gov/pmc/articles/PMC6114038; PMCID: PMC6114038; PMID: 30157883; …

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea… - Radiation …, 2018 - pubmed.ncbi.nlm.nih.gov
Background To assess the effect of radiochemotherapy (RCT) on proposed tumour hypoxia
marker transverse relaxation time (T2*) and to analyse the relation between T2* and 18 F …

[引用][C] Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

N Wiedenmann, H Bunea, HC Rischke… - Radiation …, 2018 - freidok.uni-freiburg.de